Lantus Buyers Line Up As Plaintiffs In Recast Class Action
Lantus insulin pen buyers are hopping on board the proposed class action-turned direct lawsuit as plaintiffs after counsel for the aggrieved medication buyers realized that the litigation accusing Sanofi-Aventis of anti-competitive...To view the full article, register now.
Already a subscriber? Click here to view full article